Vial stock

Vial Stock

HealthTech

Looking to sell Vial stock or options?

Founded: 2020Funding to Date: $109Mhttps://www.vial.com

Vial, a biotech company, aims to revolutionize drug development by focusing on hyper-scale advancements. By leveraging significantly more affordable trials and computationally designed therapeutics, Vial facilitates the progression of programs into the clinic. This approach empowers biotechnology companies to advance through various trial phases and partner with clinics to boost their revenue.

Investors Include:

General Catalyst, TriplePoint Venture Growth BDC, Buckley Ventures, TriplePoint Capital, BoxGroup, Byers Capital.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more